

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.62826785 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.40306451 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.31975315 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.30790724 |
| 5 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.17419606 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.14520793 |
| 7 | vocalization behavior (GO:0071625) | 5.10290956 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.99796030 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.87622450 |
| 10 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.83120058 |
| 11 | glutamate secretion (GO:0014047) | 4.61063371 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 4.60085843 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.51806117 |
| 14 | protein localization to synapse (GO:0035418) | 4.49655376 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.46405618 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.45762014 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 4.44802564 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 4.40759879 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.38190472 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.31609118 |
| 21 | exploration behavior (GO:0035640) | 4.30112127 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.29210491 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.24138682 |
| 24 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.23712787 |
| 25 | neuronal action potential propagation (GO:0019227) | 4.22045811 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19387654 |
| 27 | negative regulation of cell killing (GO:0031342) | 4.19387654 |
| 28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.15458085 |
| 29 | endothelium development (GO:0003158) | 4.14207413 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 4.01450280 |
| 31 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.00053765 |
| 32 | long-term memory (GO:0007616) | 3.97342773 |
| 33 | Notch signaling involved in heart development (GO:0061314) | 3.96796111 |
| 34 | blood vessel maturation (GO:0001955) | 3.89131963 |
| 35 | regulation of postsynaptic membrane potential (GO:0060078) | 3.85197481 |
| 36 | regulation of synaptic plasticity (GO:0048167) | 3.81901999 |
| 37 | long-term synaptic potentiation (GO:0060291) | 3.80492020 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.79673063 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75883271 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.75098584 |
| 41 | neurotransmitter secretion (GO:0007269) | 3.74836580 |
| 42 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.69998147 |
| 43 | regulation of dendritic spine development (GO:0060998) | 3.68867695 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 3.66778226 |
| 45 | layer formation in cerebral cortex (GO:0021819) | 3.66577889 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.56112625 |
| 47 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.55953097 |
| 48 | behavioral defense response (GO:0002209) | 3.53584102 |
| 49 | behavioral fear response (GO:0001662) | 3.53584102 |
| 50 | neuron recognition (GO:0008038) | 3.52928305 |
| 51 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.52768106 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.52070711 |
| 53 | regulation of glutamate secretion (GO:0014048) | 3.50501041 |
| 54 | prepulse inhibition (GO:0060134) | 3.48415097 |
| 55 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.48316625 |
| 56 | response to histamine (GO:0034776) | 3.48256305 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 3.39885685 |
| 58 | positive regulation of neurotransmitter transport (GO:0051590) | 3.39684472 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.37094999 |
| 60 | cellular potassium ion homeostasis (GO:0030007) | 3.30588545 |
| 61 | presynaptic membrane assembly (GO:0097105) | 3.28140922 |
| 62 | neuromuscular process controlling balance (GO:0050885) | 3.27333183 |
| 63 | synaptic transmission, dopaminergic (GO:0001963) | 3.26665332 |
| 64 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26645301 |
| 65 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.25469364 |
| 66 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.24536079 |
| 67 | learning (GO:0007612) | 3.23458095 |
| 68 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.22968454 |
| 69 | fear response (GO:0042596) | 3.22817981 |
| 70 | vesicle transport along microtubule (GO:0047496) | 3.22115661 |
| 71 | positive regulation of dendritic spine development (GO:0060999) | 3.20450199 |
| 72 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.19484748 |
| 73 | response to amphetamine (GO:0001975) | 3.18297822 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.15841792 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.14334354 |
| 76 | activation of protein kinase A activity (GO:0034199) | 3.12960943 |
| 77 | membrane depolarization (GO:0051899) | 3.12733486 |
| 78 | axonal fasciculation (GO:0007413) | 3.11637709 |
| 79 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.08945548 |
| 80 | behavioral response to cocaine (GO:0048148) | 3.08532402 |
| 81 | presynaptic membrane organization (GO:0097090) | 3.07560100 |
| 82 | regulation of Rap GTPase activity (GO:0032317) | 3.04258466 |
| 83 | nerve growth factor signaling pathway (GO:0038180) | 3.03046955 |
| 84 | negative regulation of amino acid transport (GO:0051956) | 3.02603402 |
| 85 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.02463020 |
| 86 | synaptic vesicle endocytosis (GO:0048488) | 3.01707654 |
| 87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.01618994 |
| 88 | postsynaptic membrane organization (GO:0001941) | 3.01566195 |
| 89 | auditory behavior (GO:0031223) | 3.00968997 |
| 90 | positive regulation of synaptic transmission (GO:0050806) | 2.97403024 |
| 91 | neurotransmitter transport (GO:0006836) | 2.96145252 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 2.94324802 |
| 93 | sprouting angiogenesis (GO:0002040) | 2.94122656 |
| 94 | dendritic spine organization (GO:0097061) | 2.93874793 |
| 95 | morphogenesis of an endothelium (GO:0003159) | 2.92841210 |
| 96 | endothelial tube morphogenesis (GO:0061154) | 2.92841210 |
| 97 | regulation of synaptic transmission (GO:0050804) | 2.90837068 |
| 98 | Rap protein signal transduction (GO:0032486) | 2.90678533 |
| 99 | visual learning (GO:0008542) | 2.90652510 |
| 100 | long term synaptic depression (GO:0060292) | 2.90553435 |
| 101 | regulation of female receptivity (GO:0045924) | 2.90093349 |
| 102 | dopamine receptor signaling pathway (GO:0007212) | 2.90031223 |
| 103 | proline transport (GO:0015824) | 2.88538600 |
| 104 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88420752 |
| 105 | regulation of neurotransmitter levels (GO:0001505) | 2.85785003 |
| 106 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.85332278 |
| 107 | protein localization to endosome (GO:0036010) | 2.84843992 |
| 108 | mechanosensory behavior (GO:0007638) | 2.82402359 |
| 109 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.81539818 |
| 110 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.77346758 |
| 111 | positive regulation of fibroblast migration (GO:0010763) | 2.75088218 |
| 112 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.72670393 |
| 113 | interkinetic nuclear migration (GO:0022027) | 2.72203168 |
| 114 | organelle transport along microtubule (GO:0072384) | 2.68366684 |
| 115 | positive regulation of vasculogenesis (GO:2001214) | 2.57472613 |
| 116 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.53628965 |
| 117 | lipid translocation (GO:0034204) | 2.52748458 |
| 118 | phospholipid translocation (GO:0045332) | 2.52748458 |
| 119 | cell adhesion mediated by integrin (GO:0033627) | 2.50089019 |
| 120 | cellular response to ethanol (GO:0071361) | 2.42780055 |
| 121 | response to nerve growth factor (GO:1990089) | 2.42367834 |
| 122 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.42367834 |
| 123 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.41891952 |
| 124 | establishment of mitochondrion localization (GO:0051654) | 2.41762560 |
| 125 | regulation of protein polyubiquitination (GO:1902914) | 2.41568236 |
| 126 | wound healing, spreading of epidermal cells (GO:0035313) | 2.40687958 |
| 127 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.39129423 |
| 128 | positive regulation of Rap GTPase activity (GO:0032854) | 2.37218489 |
| 129 | definitive hemopoiesis (GO:0060216) | 2.36327199 |
| 130 | neural tube formation (GO:0001841) | 2.36214438 |
| 131 | positive regulation of T cell cytokine production (GO:0002726) | 2.34114200 |
| 132 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.33784330 |
| 133 | regulation of Rac protein signal transduction (GO:0035020) | 2.31725883 |
| 134 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.31559114 |
| 135 | negative regulation of neurotransmitter transport (GO:0051589) | 2.28340327 |
| 136 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.26901428 |
| 137 | clathrin coat assembly (GO:0048268) | 2.22107621 |
| 138 | T cell migration (GO:0072678) | 2.21857250 |
| 139 | protein targeting to vacuole (GO:0006623) | 2.20870565 |
| 140 | protein targeting to lysosome (GO:0006622) | 2.20870565 |
| 141 | establishment of protein localization to vacuole (GO:0072666) | 2.20870565 |
| 142 | protein targeting to Golgi (GO:0000042) | 2.20338067 |
| 143 | negative regulation of anoikis (GO:2000811) | 2.19609108 |
| 144 | establishment of nucleus localization (GO:0040023) | 2.18078239 |
| 145 | lymphangiogenesis (GO:0001946) | 2.18061959 |
| 146 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.15588445 |
| 147 | nucleus localization (GO:0051647) | 2.15512962 |
| 148 | signal complex assembly (GO:0007172) | 2.15434786 |
| 149 | establishment of protein localization to Golgi (GO:0072600) | 2.12904095 |
| 150 | regulation of sarcomere organization (GO:0060297) | 2.12372780 |
| 151 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.11317509 |
| 152 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.10903780 |
| 153 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.10903780 |
| 154 | regulation of pigment cell differentiation (GO:0050932) | 2.08265836 |
| 155 | heart trabecula morphogenesis (GO:0061384) | 2.07974274 |
| 156 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.07755937 |
| 157 | regulation of establishment of cell polarity (GO:2000114) | 2.06958549 |
| 158 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.05735907 |
| 159 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.04378505 |
| 160 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.03997557 |
| 161 | embryonic process involved in female pregnancy (GO:0060136) | 2.03887688 |
| 162 | membrane assembly (GO:0071709) | 2.02852768 |
| 163 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.02339255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.77354351 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.71818496 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.08010031 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97374359 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.95200455 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80026575 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53246795 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.51682740 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.41498050 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.41498050 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39838592 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36014019 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.35014766 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29793599 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26892803 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26344561 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23292324 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18649262 |
| 19 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.10455202 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.09321633 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06979093 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04386974 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.03390326 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02384865 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01386884 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01064996 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95648628 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93413527 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.88889495 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.87452230 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86341145 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.81101262 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78711152 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78151396 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75921420 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75762706 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74871505 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.73933725 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72382250 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69894887 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60379260 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.60306476 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.60299897 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.60299897 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.58417020 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56827936 |
| 47 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55355178 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49217943 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47622683 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46651868 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46004994 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.45748689 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44214887 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44157886 |
| 55 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42490739 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41378556 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.41178202 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41164052 |
| 59 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38210088 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36202820 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35735164 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35576893 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35509020 |
| 64 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.33994131 |
| 65 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.33295438 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.33022378 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31788866 |
| 68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30939452 |
| 69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30812431 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30037304 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30001197 |
| 72 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.29944705 |
| 73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27970812 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27834846 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27518914 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26990793 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26745786 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24414476 |
| 79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22368287 |
| 80 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22144672 |
| 81 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22096672 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21155626 |
| 83 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20717411 |
| 84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19980989 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19349508 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.18848822 |
| 87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17564057 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17066972 |
| 89 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16800904 |
| 90 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16262518 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15454361 |
| 92 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.14768276 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14682701 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13829696 |
| 95 | AR_19668381_ChIP-Seq_PC3_Human | 1.13228430 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13212793 |
| 97 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12562973 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12392329 |
| 99 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12150830 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11809513 |
| 101 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.11732179 |
| 102 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09468978 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08218645 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07452553 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07185155 |
| 106 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07084560 |
| 107 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06850496 |
| 108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06609038 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06373850 |
| 110 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06203680 |
| 111 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.06050574 |
| 112 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05738634 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05536545 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03366076 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02926513 |
| 116 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02214391 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02078330 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01704132 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01639898 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01184487 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00909020 |
| 122 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00607497 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00143695 |
| 124 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99852598 |
| 125 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99582266 |
| 126 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99528770 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99525911 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98889247 |
| 129 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.98349406 |
| 130 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98042365 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98015217 |
| 132 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97961104 |
| 133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97693025 |
| 134 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97482384 |
| 135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97320027 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97320027 |
| 137 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97190187 |
| 138 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96388685 |
| 139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96022568 |
| 140 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95892422 |
| 141 | JUN_21703547_ChIP-Seq_K562_Human | 0.95736202 |
| 142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95272462 |
| 143 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94674454 |
| 144 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94553554 |
| 145 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93569445 |
| 146 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92445221 |
| 147 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90796885 |
| 148 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.88950135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.13204060 |
| 2 | MP0003880_abnormal_central_pattern | 5.77453148 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.36063232 |
| 4 | MP0010368_abnormal_lymphatic_system | 4.14010805 |
| 5 | MP0002822_catalepsy | 3.92065716 |
| 6 | MP0009745_abnormal_behavioral_response | 3.80611340 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.59492234 |
| 8 | MP0004270_analgesia | 3.49653923 |
| 9 | MP0001879_abnormal_lymphatic_vessel | 3.29777879 |
| 10 | MP0002064_seizures | 3.20779807 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 3.10399351 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.05535496 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.92786841 |
| 14 | MP0003724_increased_susceptibility_to | 2.83612416 |
| 15 | MP0009046_muscle_twitch | 2.74907519 |
| 16 | MP0006054_spinal_hemorrhage | 2.66977628 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.59018376 |
| 18 | MP0002272_abnormal_nervous_system | 2.55902862 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.53590131 |
| 20 | MP0001486_abnormal_startle_reflex | 2.50498092 |
| 21 | MP0002736_abnormal_nociception_after | 2.49055841 |
| 22 | MP0003091_abnormal_cell_migration | 2.15651430 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.11650157 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.06921341 |
| 25 | MP0003828_pulmonary_edema | 2.02490590 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.96969442 |
| 27 | MP0008569_lethality_at_weaning | 1.90540453 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.84515729 |
| 29 | MP0004924_abnormal_behavior | 1.82607840 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.82607840 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.81973469 |
| 32 | MP0003329_amyloid_beta_deposits | 1.79556256 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.79117416 |
| 34 | MP0008057_abnormal_DNA_replication | 1.73420062 |
| 35 | MP0001970_abnormal_pain_threshold | 1.69472576 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.68504875 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.62440797 |
| 38 | MP0000778_abnormal_nervous_system | 1.62316243 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.61667005 |
| 40 | MP0001529_abnormal_vocalization | 1.61492063 |
| 41 | MP0001188_hyperpigmentation | 1.61066656 |
| 42 | MP0002009_preneoplasia | 1.60921469 |
| 43 | MP0004272_abnormal_basement_membrane | 1.58786116 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.58450750 |
| 45 | MP0003787_abnormal_imprinting | 1.58240086 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.53817185 |
| 47 | MP0005409_darkened_coat_color | 1.52293950 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.49981761 |
| 49 | MP0002184_abnormal_innervation | 1.49377543 |
| 50 | MP0001915_intracranial_hemorrhage | 1.48265179 |
| 51 | MP0003633_abnormal_nervous_system | 1.45483579 |
| 52 | MP0004510_myositis | 1.44438385 |
| 53 | MP0001905_abnormal_dopamine_level | 1.42439272 |
| 54 | MP0008260_abnormal_autophagy | 1.38200402 |
| 55 | MP0000767_abnormal_smooth_muscle | 1.37230752 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.34810740 |
| 57 | MP0000955_abnormal_spinal_cord | 1.33852944 |
| 58 | MP0002066_abnormal_motor_capabilities/c | 1.30669771 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.29530465 |
| 60 | MP0004885_abnormal_endolymph | 1.29171802 |
| 61 | MP0003279_aneurysm | 1.26753890 |
| 62 | MP0005187_abnormal_penis_morphology | 1.24465662 |
| 63 | MP0003879_abnormal_hair_cell | 1.23720250 |
| 64 | MP0008874_decreased_physiological_sensi | 1.21737170 |
| 65 | MP0005595_abnormal_vascular_smooth | 1.19955583 |
| 66 | MP0003631_nervous_system_phenotype | 1.19705511 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.19510482 |
| 68 | MP0003075_altered_response_to | 1.18991182 |
| 69 | MP0003045_fibrosis | 1.16844323 |
| 70 | MP0001984_abnormal_olfaction | 1.16326658 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.15825427 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.13763285 |
| 73 | MP0004858_abnormal_nervous_system | 1.09770845 |
| 74 | MP0008872_abnormal_physiological_respon | 1.08807660 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.08572968 |
| 76 | MP0000604_amyloidosis | 1.06116684 |
| 77 | MP0002133_abnormal_respiratory_system | 1.05672227 |
| 78 | MP0005388_respiratory_system_phenotype | 1.05672227 |
| 79 | MP0000920_abnormal_myelination | 1.05252373 |
| 80 | MP0006276_abnormal_autonomic_nervous | 1.02870081 |
| 81 | MP0002152_abnormal_brain_morphology | 1.00781046 |
| 82 | MP0001958_emphysema | 0.98237609 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.95147606 |
| 84 | MP0010234_abnormal_vibrissa_follicle | 0.94263510 |
| 85 | MP0001299_abnormal_eye_distance/ | 0.94212709 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.91952744 |
| 87 | MP0001851_eye_inflammation | 0.91669976 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.89226274 |
| 89 | MP0005621_abnormal_cell_physiology | 0.88965548 |
| 90 | MP0004742_abnormal_vestibular_system | 0.88539063 |
| 91 | MP0000249_abnormal_blood_vessel | 0.88505839 |
| 92 | MP0004142_abnormal_muscle_tone | 0.87417105 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.87150503 |
| 94 | MP0002925_abnormal_cardiovascular_devel | 0.86929511 |
| 95 | MP0003303_peritoneal_inflammation | 0.85603889 |
| 96 | MP0004484_altered_response_of | 0.84881379 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.83640520 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.83294037 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 0.83085491 |
| 100 | MP0001177_atelectasis | 0.82606450 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.82564188 |
| 102 | MP0005171_absent_coat_pigmentation | 0.79857258 |
| 103 | MP0003690_abnormal_glial_cell | 0.77503710 |
| 104 | MP0003632_abnormal_nervous_system | 0.77268606 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.76882275 |
| 106 | MP0004883_abnormal_blood_vessel | 0.76133600 |
| 107 | MP0005535_abnormal_body_temperature | 0.74800867 |
| 108 | MP0003448_altered_tumor_morphology | 0.74644024 |
| 109 | MP0004085_abnormal_heartbeat | 0.74576619 |
| 110 | MP0001784_abnormal_fluid_regulation | 0.72970152 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.71861664 |
| 112 | MP0002128_abnormal_blood_circulation | 0.70981151 |
| 113 | MP0001191_abnormal_skin_condition | 0.70525082 |
| 114 | MP0001614_abnormal_blood_vessel | 0.69956576 |
| 115 | MP0002127_abnormal_cardiovascular_syste | 0.69754413 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.69524083 |
| 117 | MP0003436_decreased_susceptibility_to | 0.67845458 |
| 118 | MP0003634_abnormal_glial_cell | 0.66707736 |
| 119 | MP0005166_decreased_susceptibility_to | 0.66573173 |
| 120 | MP0009764_decreased_sensitivity_to | 0.66018343 |
| 121 | MP0003385_abnormal_body_wall | 0.65014143 |
| 122 | MP0004134_abnormal_chest_morphology | 0.64992419 |
| 123 | MP0005000_abnormal_immune_tolerance | 0.64688611 |
| 124 | MP0002229_neurodegeneration | 0.63662122 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.63440030 |
| 126 | MP0000733_abnormal_muscle_development | 0.61679213 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.60420094 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.59982441 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.58679844 |
| 130 | MP0006138_congestive_heart_failure | 0.58625283 |
| 131 | MP0004947_skin_inflammation | 0.58501563 |
| 132 | MP0005671_abnormal_response_to | 0.58453336 |
| 133 | MP0002405_respiratory_system_inflammati | 0.58449336 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.56499146 |
| 135 | MP0005174_abnormal_tail_pigmentation | 0.53851436 |
| 136 | MP0000631_abnormal_neuroendocrine_gland | 0.53622310 |
| 137 | MP0001943_abnormal_respiration | 0.52203259 |
| 138 | MP0008877_abnormal_DNA_methylation | 0.51093302 |
| 139 | MP0010769_abnormal_survival | 0.50984925 |
| 140 | MP0001664_abnormal_digestion | 0.50539245 |
| 141 | MP0002082_postnatal_lethality | 0.48452809 |
| 142 | MP0010770_preweaning_lethality | 0.48452809 |
| 143 | MP0010768_mortality/aging | 0.47811760 |
| 144 | MP0003956_abnormal_body_size | 0.46954252 |
| 145 | MP0004215_abnormal_myocardial_fiber | 0.46542859 |
| 146 | MP0000751_myopathy | 0.46162751 |
| 147 | MP0003861_abnormal_nervous_system | 0.45152826 |
| 148 | MP0003300_gastrointestinal_ulcer | 0.44744713 |
| 149 | MP0003122_maternal_imprinting | 0.44638167 |
| 150 | MP0004145_abnormal_muscle_electrophysio | 0.43264986 |
| 151 | MP0003763_abnormal_thymus_physiology | 0.41016176 |
| 152 | MP0002752_abnormal_somatic_nervous | 0.40053323 |
| 153 | MP0002090_abnormal_vision | 0.40044491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.09631976 |
| 2 | Myokymia (HP:0002411) | 6.33775109 |
| 3 | Focal seizures (HP:0007359) | 5.92526930 |
| 4 | Visual hallucinations (HP:0002367) | 4.99338065 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.84801671 |
| 6 | Atonic seizures (HP:0010819) | 4.59965798 |
| 7 | Febrile seizures (HP:0002373) | 4.20652811 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 4.18796590 |
| 9 | Broad-based gait (HP:0002136) | 4.02044759 |
| 10 | Absence seizures (HP:0002121) | 4.00997056 |
| 11 | Hyperventilation (HP:0002883) | 3.87393382 |
| 12 | Dialeptic seizures (HP:0011146) | 3.86749022 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.86397044 |
| 14 | Poor eye contact (HP:0000817) | 3.81866405 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.72343389 |
| 16 | Action tremor (HP:0002345) | 3.58772228 |
| 17 | Amblyopia (HP:0000646) | 3.37734691 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.37694344 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.35758291 |
| 20 | Diplopia (HP:0000651) | 3.33502425 |
| 21 | Abnormality of binocular vision (HP:0011514) | 3.33502425 |
| 22 | Truncal ataxia (HP:0002078) | 3.33498670 |
| 23 | Impaired social interactions (HP:0000735) | 3.29735172 |
| 24 | Abnormal social behavior (HP:0012433) | 3.29735172 |
| 25 | Scanning speech (HP:0002168) | 3.24673460 |
| 26 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.23757752 |
| 27 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.23757752 |
| 28 | Dysmetria (HP:0001310) | 3.22443670 |
| 29 | Impaired smooth pursuit (HP:0007772) | 3.16126876 |
| 30 | Papilledema (HP:0001085) | 3.12623668 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 3.09101228 |
| 32 | Drooling (HP:0002307) | 3.00768668 |
| 33 | Excessive salivation (HP:0003781) | 3.00768668 |
| 34 | Stereotypic behavior (HP:0000733) | 3.00540633 |
| 35 | Spontaneous hematomas (HP:0007420) | 3.00132628 |
| 36 | Anxiety (HP:0000739) | 2.99543511 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.98702902 |
| 38 | Urinary urgency (HP:0000012) | 2.95151300 |
| 39 | Depression (HP:0000716) | 2.94381969 |
| 40 | Dysdiadochokinesis (HP:0002075) | 2.93505418 |
| 41 | Progressive inability to walk (HP:0002505) | 2.88563458 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.86637738 |
| 43 | Genetic anticipation (HP:0003743) | 2.78069399 |
| 44 | Ankle clonus (HP:0011448) | 2.70568988 |
| 45 | Annular pancreas (HP:0001734) | 2.69897573 |
| 46 | Postural instability (HP:0002172) | 2.68963897 |
| 47 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.67371876 |
| 48 | Thyroid carcinoma (HP:0002890) | 2.66422364 |
| 49 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.63427549 |
| 50 | Dysmetric saccades (HP:0000641) | 2.60636582 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.53385848 |
| 52 | Arterial tortuosity (HP:0005116) | 2.52190100 |
| 53 | Hemiparesis (HP:0001269) | 2.44576381 |
| 54 | Absent speech (HP:0001344) | 2.43339068 |
| 55 | Bradykinesia (HP:0002067) | 2.42834791 |
| 56 | Mutism (HP:0002300) | 2.42381414 |
| 57 | Amyotrophic lateral sclerosis (HP:0007354) | 2.41971190 |
| 58 | Protruding tongue (HP:0010808) | 2.39777800 |
| 59 | Inability to walk (HP:0002540) | 2.38140213 |
| 60 | Subacute progressive viral hepatitis (HP:0006572) | 2.37795971 |
| 61 | Hemiplegia (HP:0002301) | 2.37537388 |
| 62 | Spastic gait (HP:0002064) | 2.35637627 |
| 63 | T lymphocytopenia (HP:0005403) | 2.34113530 |
| 64 | Intention tremor (HP:0002080) | 2.32075760 |
| 65 | Termporal pattern (HP:0011008) | 2.32054274 |
| 66 | Insidious onset (HP:0003587) | 2.32054274 |
| 67 | Inappropriate behavior (HP:0000719) | 2.31891478 |
| 68 | Blue irides (HP:0000635) | 2.31840008 |
| 69 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.27484071 |
| 70 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.27484071 |
| 71 | Torticollis (HP:0000473) | 2.26623143 |
| 72 | Vascular tortuosity (HP:0004948) | 2.25381657 |
| 73 | Abnormal eating behavior (HP:0100738) | 2.22663553 |
| 74 | Megalencephaly (HP:0001355) | 2.21296116 |
| 75 | Absent hand (HP:0004050) | 2.20989956 |
| 76 | Impaired vibratory sensation (HP:0002495) | 2.18128885 |
| 77 | Focal dystonia (HP:0004373) | 2.16967574 |
| 78 | Overgrowth (HP:0001548) | 2.16883359 |
| 79 | Pointed chin (HP:0000307) | 2.16852776 |
| 80 | Pelvic girdle muscle weakness (HP:0003749) | 2.15465076 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.14746808 |
| 82 | Abnormality of the lower motor neuron (HP:0002366) | 2.14527005 |
| 83 | Thickened helices (HP:0000391) | 2.13736974 |
| 84 | Lower limb asymmetry (HP:0100559) | 2.13569253 |
| 85 | Epileptiform EEG discharges (HP:0011182) | 2.12302914 |
| 86 | Aortic aneurysm (HP:0004942) | 2.10440412 |
| 87 | Abnormality of T cell number (HP:0011839) | 2.10347364 |
| 88 | Resting tremor (HP:0002322) | 2.08327581 |
| 89 | Dyskinesia (HP:0100660) | 2.07746918 |
| 90 | Autoamputation (HP:0001218) | 2.07444109 |
| 91 | Ankyloglossia (HP:0010296) | 2.06749369 |
| 92 | Hematochezia (HP:0002573) | 2.04121457 |
| 93 | Abnormality of the periventricular white matter (HP:0002518) | 2.02775663 |
| 94 | Cortical dysplasia (HP:0002539) | 2.00894634 |
| 95 | Lower limb muscle weakness (HP:0007340) | 2.00428483 |
| 96 | Abnormality of salivation (HP:0100755) | 1.99983628 |
| 97 | Abnormality of oral frenula (HP:0000190) | 1.99103833 |
| 98 | Deeply set eye (HP:0000490) | 1.97831166 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 1.97633495 |
| 100 | Large earlobe (HP:0009748) | 1.96858231 |
| 101 | Shoulder girdle muscle weakness (HP:0003547) | 1.92103015 |
| 102 | Incomplete penetrance (HP:0003829) | 1.92069799 |
| 103 | Heterochromia iridis (HP:0001100) | 1.91469719 |
| 104 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91415955 |
| 105 | Adactyly (HP:0009776) | 1.91046514 |
| 106 | Craniofacial dystonia (HP:0012179) | 1.91003835 |
| 107 | Portal hypertension (HP:0001409) | 1.90982898 |
| 108 | Widely spaced teeth (HP:0000687) | 1.90514809 |
| 109 | Generalized hypopigmentation of hair (HP:0011358) | 1.90097202 |
| 110 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89371938 |
| 111 | Vertebral arch anomaly (HP:0008438) | 1.89167494 |
| 112 | Type II lissencephaly (HP:0007260) | 1.88270082 |
| 113 | Apathy (HP:0000741) | 1.87952573 |
| 114 | Tetraparesis (HP:0002273) | 1.87698928 |
| 115 | Status epilepticus (HP:0002133) | 1.86507303 |
| 116 | Wrist flexion contracture (HP:0001239) | 1.86297798 |
| 117 | Gait ataxia (HP:0002066) | 1.84745327 |
| 118 | Peripheral hypomyelination (HP:0007182) | 1.84149518 |
| 119 | Deep palmar crease (HP:0006191) | 1.83509090 |
| 120 | Slow saccadic eye movements (HP:0000514) | 1.83467769 |
| 121 | Obstructive sleep apnea (HP:0002870) | 1.82838937 |
| 122 | Skull defect (HP:0001362) | 1.82353101 |
| 123 | Fetal akinesia sequence (HP:0001989) | 1.81951307 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 1.81526935 |
| 125 | Psychosis (HP:0000709) | 1.81396706 |
| 126 | Bladder neoplasm (HP:0009725) | 1.81328738 |
| 127 | Bladder carcinoma (HP:0002862) | 1.81328738 |
| 128 | Difficulty running (HP:0009046) | 1.80797126 |
| 129 | Heterotopia (HP:0002282) | 1.80567697 |
| 130 | Disinhibition (HP:0000734) | 1.80148221 |
| 131 | Fair hair (HP:0002286) | 1.80024642 |
| 132 | Split foot (HP:0001839) | 1.79352662 |
| 133 | Abnormality of saccadic eye movements (HP:0000570) | 1.78033162 |
| 134 | Spastic paraplegia (HP:0001258) | 1.77750516 |
| 135 | Hypoplasia of the iris (HP:0007676) | 1.76894887 |
| 136 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.76449254 |
| 137 | Absent frontal sinuses (HP:0002688) | 1.75959042 |
| 138 | Clumsiness (HP:0002312) | 1.75773616 |
| 139 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.75745554 |
| 140 | Hypsarrhythmia (HP:0002521) | 1.75631311 |
| 141 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.75039940 |
| 142 | Conjunctival telangiectasia (HP:0000524) | 1.74762014 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.73927727 |
| 144 | Curly hair (HP:0002212) | 1.72633089 |
| 145 | Paraplegia (HP:0010550) | 1.72469937 |
| 146 | Medulloblastoma (HP:0002885) | 1.71937892 |
| 147 | Clonus (HP:0002169) | 1.71663806 |
| 148 | Esophageal varix (HP:0002040) | 1.70711837 |
| 149 | Diminished motivation (HP:0000745) | 1.67733612 |
| 150 | Hammertoe (HP:0001765) | 1.66795966 |
| 151 | Decreased motor nerve conduction velocity (HP:0003431) | 1.64910610 |
| 152 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.63578528 |
| 153 | Abnormality of the hepatic vasculature (HP:0006707) | 1.63288898 |
| 154 | Exotropia (HP:0000577) | 1.62838710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.14918841 |
| 2 | TIE1 | 5.83044275 |
| 3 | NTRK3 | 4.46645419 |
| 4 | RIPK4 | 3.50688282 |
| 5 | MAP3K9 | 3.35404582 |
| 6 | MAP3K4 | 2.73543524 |
| 7 | MAP3K13 | 2.68387057 |
| 8 | BCR | 2.57783131 |
| 9 | DAPK2 | 2.45827315 |
| 10 | KSR2 | 2.37976845 |
| 11 | MAP2K7 | 2.35952965 |
| 12 | MINK1 | 2.20195482 |
| 13 | MAP3K12 | 2.09704593 |
| 14 | MARK1 | 2.03935804 |
| 15 | KSR1 | 1.99267198 |
| 16 | FES | 1.94977071 |
| 17 | TNIK | 1.93541065 |
| 18 | NTRK2 | 1.90504445 |
| 19 | DAPK1 | 1.84247715 |
| 20 | SIK2 | 1.83309174 |
| 21 | PAK6 | 1.78120290 |
| 22 | CAMKK1 | 1.75458536 |
| 23 | EPHA3 | 1.70364798 |
| 24 | RAF1 | 1.60294931 |
| 25 | NEK9 | 1.59084834 |
| 26 | MAP2K4 | 1.55592960 |
| 27 | CDK19 | 1.54711043 |
| 28 | CDK5 | 1.49405594 |
| 29 | PNCK | 1.48498310 |
| 30 | PLK2 | 1.43698084 |
| 31 | PRKD3 | 1.42647489 |
| 32 | BMPR2 | 1.41814293 |
| 33 | CAMKK2 | 1.39643942 |
| 34 | BRD4 | 1.39373978 |
| 35 | NTRK1 | 1.39121884 |
| 36 | ERBB3 | 1.35873178 |
| 37 | TGFBR2 | 1.33783281 |
| 38 | TYRO3 | 1.31844021 |
| 39 | TEC | 1.29928011 |
| 40 | JAK1 | 1.22449454 |
| 41 | ARAF | 1.20052010 |
| 42 | CASK | 1.15595507 |
| 43 | PTK2B | 1.14873934 |
| 44 | CSK | 1.14013927 |
| 45 | PRPF4B | 1.11990044 |
| 46 | FER | 1.10994935 |
| 47 | PDGFRA | 1.09409284 |
| 48 | MAP3K5 | 1.07796330 |
| 49 | MAP3K14 | 1.05605847 |
| 50 | PINK1 | 1.05098537 |
| 51 | CDK6 | 1.03552710 |
| 52 | MAPK13 | 0.98002005 |
| 53 | IKBKE | 0.96460921 |
| 54 | STK11 | 0.93949452 |
| 55 | PRKCH | 0.93671392 |
| 56 | MAP3K2 | 0.93384949 |
| 57 | KDR | 0.93148035 |
| 58 | YES1 | 0.90771821 |
| 59 | PIK3CG | 0.89411740 |
| 60 | PDK1 | 0.88770869 |
| 61 | CAMK2B | 0.88716562 |
| 62 | CAMK2A | 0.87891172 |
| 63 | TXK | 0.87885735 |
| 64 | FGR | 0.87272232 |
| 65 | PRKCG | 0.85337424 |
| 66 | TAOK1 | 0.84985296 |
| 67 | GRK6 | 0.84645508 |
| 68 | GRK5 | 0.82731779 |
| 69 | RET | 0.81815226 |
| 70 | SGK1 | 0.81279545 |
| 71 | DMPK | 0.80829185 |
| 72 | SGK2 | 0.77807795 |
| 73 | MARK2 | 0.76751639 |
| 74 | CAMK1 | 0.76575482 |
| 75 | TNK2 | 0.76330542 |
| 76 | EPHB1 | 0.72895379 |
| 77 | SGK223 | 0.72714766 |
| 78 | SGK494 | 0.72714766 |
| 79 | CSNK1A1L | 0.70048682 |
| 80 | MAP3K7 | 0.69558867 |
| 81 | PDPK1 | 0.68340607 |
| 82 | ZAP70 | 0.67249357 |
| 83 | PRKCQ | 0.66611796 |
| 84 | LATS1 | 0.66074447 |
| 85 | AKT3 | 0.65820616 |
| 86 | CDK18 | 0.65786397 |
| 87 | LATS2 | 0.65066335 |
| 88 | UHMK1 | 0.64898762 |
| 89 | STK38 | 0.64553947 |
| 90 | CDK15 | 0.63778715 |
| 91 | SGK3 | 0.63667941 |
| 92 | SYK | 0.63494557 |
| 93 | MAP3K1 | 0.63293091 |
| 94 | FGFR3 | 0.62353421 |
| 95 | CSNK1G2 | 0.62257424 |
| 96 | EGFR | 0.61370173 |
| 97 | CLK1 | 0.61218623 |
| 98 | DYRK1B | 0.60630689 |
| 99 | CDK14 | 0.60571102 |
| 100 | JAK2 | 0.57096450 |
| 101 | DYRK1A | 0.56950240 |
| 102 | BTK | 0.56890162 |
| 103 | TGFBR1 | 0.56814786 |
| 104 | ALK | 0.56771613 |
| 105 | CDK11A | 0.55249318 |
| 106 | MAP3K6 | 0.54913818 |
| 107 | LCK | 0.54865822 |
| 108 | FYN | 0.51708967 |
| 109 | RIPK1 | 0.50818481 |
| 110 | INSRR | 0.48776182 |
| 111 | FGFR2 | 0.48667767 |
| 112 | CDK12 | 0.48665502 |
| 113 | OXSR1 | 0.45312939 |
| 114 | RPS6KB1 | 0.44996641 |
| 115 | HCK | 0.44736532 |
| 116 | TRIM28 | 0.43510180 |
| 117 | SIK3 | 0.43163535 |
| 118 | MAPK10 | 0.41597245 |
| 119 | PAK3 | 0.41547978 |
| 120 | MAPK12 | 0.40879831 |
| 121 | RPS6KA3 | 0.39560554 |
| 122 | ROCK2 | 0.37155697 |
| 123 | MOS | 0.36286113 |
| 124 | SCYL2 | 0.34916499 |
| 125 | CCNB1 | 0.31784012 |
| 126 | CAMK4 | 0.31422749 |
| 127 | DAPK3 | 0.30177740 |
| 128 | NEK6 | 0.29623104 |
| 129 | PRKCE | 0.29369278 |
| 130 | MAP2K1 | 0.28390182 |
| 131 | PRKCZ | 0.27673040 |
| 132 | PRKCB | 0.27589444 |
| 133 | PDGFRB | 0.27397393 |
| 134 | CAMK1G | 0.26924967 |
| 135 | PRKD2 | 0.26320871 |
| 136 | CAMK2D | 0.25657009 |
| 137 | MAP4K1 | 0.25129108 |
| 138 | MAPK7 | 0.25019260 |
| 139 | JAK3 | 0.22900670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.35773398 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 3.00947620 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62059510 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57349344 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.54197601 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.52150889 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.48199254 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.44630653 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31481354 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.23783169 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11618899 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.07399800 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 1.87379538 |
| 14 | Long-term depression_Homo sapiens_hsa04730 | 1.85583901 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79889360 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75987708 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75897179 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75203413 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69439644 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66838707 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59054392 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53526199 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.49730488 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.49086559 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44544318 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44043717 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42349126 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33437849 |
| 29 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31673269 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.31393275 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.30760255 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30202585 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.30040027 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22476873 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20683096 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17268178 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16970787 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.15834422 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.13188714 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12155399 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10587406 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10497126 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09807739 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.08517446 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07979548 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04524550 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03166722 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.02885630 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02287488 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 1.01434072 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 1.00907016 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99744059 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.99065598 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98806906 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98550342 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95535689 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95255427 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93386271 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.93276446 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92205373 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.91983953 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91462930 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89460279 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89266461 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87638884 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87353221 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86618279 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86078371 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85873129 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85092657 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84498982 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83949243 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83835506 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83707142 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83293698 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83114459 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80799493 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80388338 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80265023 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80123991 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.79463433 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78608703 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77216884 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77046311 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76403630 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75572309 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75464472 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75343841 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75230274 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73268976 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73168293 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73054323 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72544346 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72066973 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71246295 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.67456412 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.66427106 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65929462 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.65348701 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65265862 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65053551 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64431902 |
| 103 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64014671 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63306414 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62190561 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61102565 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.60824872 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60352039 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59493970 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53918293 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53689563 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53518240 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53143220 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52781368 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.50841668 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49808352 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48309585 |
| 118 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48159853 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47838048 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46880060 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45071292 |
| 122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44142009 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42746052 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.42033617 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41593597 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40328172 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.40281143 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39743384 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39600855 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39502536 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36897811 |
| 132 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36106935 |

